The anti-influenza sector has made significant adjustments, with Hainan Haiyao hitting the limit down.

The flu prevention sector has undergone a significant adjustment, with Hainan Haiyao hitting the limit down, Jindike, Jiaying Pharmaceutical, Hualan Vaccine, Asia Pacific Pharmaceutical, Kangzhi Pharmaceutical, Lianhuan Pharmaceutical and others following the downward trend.